Abstract
The introduction of drug eluting stents (DES) has the potential to revolutionize interventional cardiology. Despite the dramatic improvements demonstrated in randomised trials of the currently available DES restenosis still occurs in complex lesions. An effective DES requires the combination of a stent, a drug delivery system such as a polymer and pharmaceutical agent. This article will summarize some of the recent developments in the rapidly evolving field of drug delivery platforms.
Keywords: drug eluting stent, restenosis, polymer coating, angioplasty
Current Cardiology Reviews
Title: New Drug-Eluting Stent Technologies
Volume: 1 Issue: 3
Author(s): Lei Ge, John Cosgrave, Ioannis Iakovou, Giuseppe M. Sangiorgi and Antonio Colombo
Affiliation:
Keywords: drug eluting stent, restenosis, polymer coating, angioplasty
Abstract: The introduction of drug eluting stents (DES) has the potential to revolutionize interventional cardiology. Despite the dramatic improvements demonstrated in randomised trials of the currently available DES restenosis still occurs in complex lesions. An effective DES requires the combination of a stent, a drug delivery system such as a polymer and pharmaceutical agent. This article will summarize some of the recent developments in the rapidly evolving field of drug delivery platforms.
Export Options
About this article
Cite this article as:
Ge Lei, Cosgrave John, Iakovou Ioannis, Sangiorgi M. Giuseppe and Colombo Antonio, New Drug-Eluting Stent Technologies, Current Cardiology Reviews 2005; 1 (3) . https://dx.doi.org/10.2174/157340305774574107
DOI https://dx.doi.org/10.2174/157340305774574107 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blood-Brain Barrier Penetration and Drug Development from an Industrial Point of View
Current Medicinal Chemistry - Central Nervous System Agents Editorial [Hot Topic: Phosphodiesterase 5 Inhibitors: Pharmacology and Therapeutic Perspectives (Executive Editor: Giuseppe Barbaro)]
Current Pharmaceutical Design Strategies to Avoid TAVI-related Acute Kidney Injury
Current Pharmaceutical Design Editorial: [Statins and Cardiovascular Events in Patients with End-Stage Renal Disease on Hemodialysis. The AURORA Results Suggest the Need for Earlier Intervention]
Current Vascular Pharmacology A Novel Application of Three Phase Hollow Fiber Based Liquid Phase Microextraction (HF-LPME) for the HPLC Determination of Tamsulosin from Biological Fluids
Current Pharmaceutical Analysis Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery Not So Simple: Situating Postgenomics Personalized Medicine in the Regional Context in Africa for Global and Womens Health
Current Pharmacogenomics and Personalized Medicine Endothelial Dysfunction and the Effects of TNF Inhibitors on the Endothelium in Psoriasis and Psoriatic Arthritis: A Systematic Review
Current Pharmaceutical Design The Role of PPARs in Obesity and other Insulin Resistance Associated Disorders
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Gender Difference in the Risk of Adverse Outcomes After Diabetic Foot Disease: A Mini-Review
Current Diabetes Reviews Glucose Lowering Activity of Anvillea Radiata Coss & Durieu in Diabetic Rats
Cardiovascular & Hematological Disorders-Drug Targets Low - Molecular Weight Heparins and Unfractionated Heparins during Primary Coronary Intervention
Cardiovascular & Hematological Agents in Medicinal Chemistry Alzheimers Disease and Immunotherapy
Current Alzheimer Research Targeting the Role of Lipoprotein (a) in Stroke
Cardiovascular & Hematological Disorders-Drug Targets Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews The Impact of Variable Factors on the Health-Related Quality of Life in the Elderly in Japan and Russia
Current Aging Science Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets Pexelizumab and its Role in the Treatment of Myocardial Infarction and in Coronary Artery Bypass Graft Surgery: A Review
Recent Patents on Cardiovascular Drug Discovery Direct Antithrombins: New Perspectives in Cardiovascular Medicine
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Zolpidem Arousing Effect in Persistent Vegetative State Patients: Autonomic, EEG and Behavioral Assessment
Current Pharmaceutical Design